Business, energy, technology, markets and global industry news from Business News Today

eplontersen

Pharma & Biotech

Aurisco passed an FDA inspection for inclisiran sodium, but the bigger story is what comes next for generic oligonucleotides

Aurisco’s FDA inspection for inclisiran sodium puts generic oligonucleotide manufacturing closer to a crucial regulatory and commercial test.

Read More
Pharma & Biotech

Ionis Pharmaceuticals shares slide as eplontersen misses key heart disease endpoint

See why the CARDIO-TTRansform miss complicates eplontersen’s ATTR-CM path and tests gene silencing on top of stabilizer therapy.

Read More